Michael Li-Hsuan Huang

Michael Li-Hsuan Huang

Auto-generated profile, based on publicly available information

Michael Li-Hsuan Huang

Molecular Pharmacology and Pathology Program, Department of Pathology and Bosch Institute, University of Sydney, Sydney, New South Wales, Australia

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 May 2010 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
DRDes Richardson
Des Richardson
DLDarius Lane
Darius Lane
EBErika M. Becker
Erika M. Becker
MHMichael L.-H. Huang
Michael L.-H. Huang
MWMegan Whitnall
Megan Whitnall
PPPrem Ponka
Prem Ponka
The mitochondrion is well known for its key role in energy transduction. However, it is less well appreciated that it is also a focal point of iron metabolism. Iron is needed not only for heme and iron sulfur cluster (ISC)-containing proteins involved in electron transport and oxidative phosphorylation, but also for a wide variety of cytoplasmic and nuclear functions, including DNA synthesis. The mitochondrial pathways involved in the generation of both heme and ISCs have been characterized to some extent. However, little is known concerning the regulation of iron uptake by the mitochondrion and how this is coordinated with iron metabolism in the cytosol and other organelles (e.g., lysosomes). In this article, we discuss the burgeoning field of mitochondrial iron metabolism and trafficking that has recently been stimulated by the discovery of proteins involved in mitochondrial iron storage (mitochondrial ferritin) and transport (mitoferrin-1 and -2). In addition, recent work examining mitochondrial diseases (e.g., Friedreich's ataxia) has established that communication exists between iron metabolism in the mitochondrion and the cytosol. This finding has revealed the ability of the mitochondrion to modulate whole-cell iron-processing to satisfy its own requirements for the crucial processes of heme and ISC synthesis. Knowledge of mitochondrial iron-processing pathways and the interaction between organelles and the cytosol could revolutionize the investigation of iron metabolism.

1 May 2015 in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Verified
Journal Article
Closed access
DLDarius Lane
Darius Lane
AMA.M. Merlot
A.M. Merlot
MHM.L.-H. Huang
M.L.-H. Huang
DBD.-H. Bae
D.-H. Bae
Patric J. JanssonPatric J. Jansson
Patric J. Jansson
DRDes Richardson
Des Richardson

22 September 2009 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
MHMichael Li-Hsuan Huang
Michael Li-Hsuan Huang
EBErika M. Becker
Erika M. Becker
MWMegan Whitnall
Megan Whitnall
YRYohan Suryo Rahmanto
Yohan Suryo Rahmanto
PPPrem Ponka
Prem Ponka
DRDes Richardson
Des Richardson
We used the muscle creatine kinase (MCK) conditional frataxin knockout mouse to elucidate how frataxin deficiency alters iron metabolism. This is of significance because frataxin deficiency leads to Friedreich's ataxia, a disease marked by neurologic and cardiologic degeneration. Using cardiac tissues, we demonstrate that frataxin deficiency leads to down-regulation of key molecules involved in 3 mitochondrial utilization pathways: iron-sulfur cluster (ISC) synthesis (iron-sulfur cluster scaffold protein1/2 and the cysteine desulferase Nfs1), mitochondrial iron storage (mitochondrial ferritin), and heme synthesis (5-aminolevulinate dehydratase, coproporphyrinogen oxidase, hydroxymethylbilane synthase, uroporphyrinogen III synthase, and ferrochelatase). This marked decrease in mitochondrial iron utilization and resultant reduced release of heme and ISC from the mitochondrion could contribute to the excessive mitochondrial iron observed. This effect is compounded by increased iron availability for mitochondrial uptake through (i) transferrin receptor1 up-regulation, increasing iron uptake from transferrin; (ii) decreased ferroportin1 expression, limiting iron export; (iii) increased expression of the heme catabolism enzyme heme oxygenase1 and down-regulation of ferritin-H and -L, both likely leading to increased “free iron” for mitochondrial uptake; and (iv) increased expression of the mammalian exocyst protein Sec15l1 and the mitochondrial iron importer mitoferrin-2 (Mfrn2), which facilitate cellular iron uptake and mitochondrial iron influx, respectively. Our results enable the construction of a model explaining the cytosolic iron deficiency and mitochondrial iron loading in the absence of frataxin, which is important for understanding the pathogenesis of Friedreich's ataxia.

1 April 2016 in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Verified
Journal Article
Closed access
JPJasmina Paluncic
Jasmina Paluncic
Zaklina KovacevicZaklina Kovacevic
Zaklina Kovacevic
Patric J. JanssonPatric J. Jansson
Patric J. Jansson
DKDanuta Kalinowski
Danuta Kalinowski
AMAngelika M. Merlot
Angelika M. Merlot
DRDes Richardson
Des Richardson

7 April 2019 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
MHMichael L.-H. Huang
Michael L.-H. Huang
SCShannon Chiang
Shannon Chiang
DKDanuta S. Kalinowski
Danuta S. Kalinowski
DBDong-Hun Bae
Dong-Hun Bae
SSSumit Sahni
Sumit Sahni
DRDes Richardson
Des Richardson
The mitochondrion is an essential organelle important for the generation of ATP for cellular function. This is especially critical for cells with high energy demands, such as neurons for signal transmission and cardiomyocytes for the continuous mechanical work of the heart. However, deleterious reactive oxygen species are generated as a result of mitochondrial electron transport, requiring a rigorous activation of antioxidative defense in order to maintain homeostatic mitochondrial function. Indeed, recent studies have demonstrated that the dysregulation of antioxidant response leads to mitochondrial dysfunction in human degenerative diseases affecting the nervous system and the heart. In this review, we outline and discuss the mitochondrial and oxidative stress factors causing degenerative diseases, such as Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, Huntington’s disease, and Friedreich’s ataxia. In particular, the pathological involvement of mitochondrial dysfunction in relation to oxidative stress, energy metabolism, mitochondrial dynamics, and cell death will be explored. Understanding the pathology and the development of these diseases has highlighted novel regulators in the homeostatic maintenance of mitochondria. Importantly, this offers potential therapeutic targets in the development of future treatments for these degenerative diseases.

1 January 2016 in Metallomics
Verified
Journal Article
Open access
PDF file
KPKyung Chan Park
Kyung Chan Park
LFLeyla Fouani
Leyla Fouani
Patric J. JanssonPatric J. Jansson
Patric J. Jansson
DWDanson Wooi
Danson Wooi
Sumit SahniSumit Sahni
Sumit Sahni
DRDes Richardson
Des Richardson
Copper is an essential trace metal required by organisms to perform a number of important biological processes. Copper readily cycles between its redu